Skip to main content
Top
Published in: BMC Gastroenterology 1/2004

Open Access 01-12-2004 | Research article

Cyclin A and cyclin D1 as significant prognostic markers in colorectal cancer patients

Authors: Abeer A Bahnassy, Abdel-Rahman N Zekri, Soumaya El-Houssini, Amal MR El-Shehaby, Moustafa Raafat Mahmoud, Samira Abdallah, Mostafa El-Serafi

Published in: BMC Gastroenterology | Issue 1/2004

Login to get access

Abstract

Background

Colorectal cancer is a common cancer all over the world. Aberrations in the cell cycle checkpoints have been shown to be of prognostic significance in colorectal cancer.

Methods

The expression of cyclin D1, cyclin A, histone H3 and Ki-67 was examined in 60 colorectal cancer cases for co-regulation and impact on overall survival using immunohistochemistry, southern blot and in situ hybridization techniques. Immunoreactivity was evaluated semi quantitatively by determining the staining index of the studied proteins.

Results

There was a significant correlation between cyclin D1 gene amplification and protein overexpression (concordance = 63.6%) and between Ki-67 and the other studied proteins. The staining index for Ki-67, cyclin A and D1 was higher in large, poorly differentiated tumors. The staining index of cyclin D1 was significantly higher in cases with deeply invasive tumors and nodal metastasis. Overexpression of cyclin A and D1 and amplification of cyclin D1 were associated with reduced overall survival. Multivariate analysis shows that cyclin D1 and A are two independent prognostic factors in colorectal cancer patients.

Conclusions

Loss of cell cycle checkpoints control is common in colorectal cancer. Cyclin A and D1 are superior independent indicators of poor prognosis in colorectal cancer patients. Therefore, they may help in predicting the clinical outcome of those patients on an individual basis and could be considered important therapeutic targets.
Appendix
Available only for authorised users
Literature
1.
go back to reference Jiang GL, Huang S: Adenovirus expressing RIZ1 in tumor suppressor gene therapy of microsatellite unstable colorectal cancers. Cancer Res. 2001, 61: 1796-1798.PubMed Jiang GL, Huang S: Adenovirus expressing RIZ1 in tumor suppressor gene therapy of microsatellite unstable colorectal cancers. Cancer Res. 2001, 61: 1796-1798.PubMed
2.
go back to reference Soliman AS, Bondy ML, Levin B, Hamza MR, Ismail K, Ismail S, Hammam HM, El-Hattab O, Kamal SM, Soliman AG, Dorgham LA, McPherson RS, Beasley RP: Colorectal cancer in Egyptian patients under 40 years of age. Int J Cancer. 1997, 71: 26-30. 10.1002/(SICI)1097-0215(19970328)71:1<26::AID-IJC6>3.0.CO;2-5.CrossRefPubMed Soliman AS, Bondy ML, Levin B, Hamza MR, Ismail K, Ismail S, Hammam HM, El-Hattab O, Kamal SM, Soliman AG, Dorgham LA, McPherson RS, Beasley RP: Colorectal cancer in Egyptian patients under 40 years of age. Int J Cancer. 1997, 71: 26-30. 10.1002/(SICI)1097-0215(19970328)71:1<26::AID-IJC6>3.0.CO;2-5.CrossRefPubMed
3.
go back to reference Soliman AS, Bondy ML, Guan Y, El-Badawy S, Mokhtar N, Bayomi S, Raouf AA, Ismail S, McPherson RS, Abdel-Hakim TF, Beasley PR, Levin B, Wei Q: Reduced expression of mismatch repair genes in colorectal cancer patients in Egypt. Int J Oncol. 1998, 12: 1315-1319.PubMed Soliman AS, Bondy ML, Guan Y, El-Badawy S, Mokhtar N, Bayomi S, Raouf AA, Ismail S, McPherson RS, Abdel-Hakim TF, Beasley PR, Levin B, Wei Q: Reduced expression of mismatch repair genes in colorectal cancer patients in Egypt. Int J Oncol. 1998, 12: 1315-1319.PubMed
4.
go back to reference Cordon-Cardo C: Mutations of cell cycle regulators. Biological and clinical implications for human neoplasia. Am J pathol. 1995, 147: 545-560.PubMedPubMedCentral Cordon-Cardo C: Mutations of cell cycle regulators. Biological and clinical implications for human neoplasia. Am J pathol. 1995, 147: 545-560.PubMedPubMedCentral
5.
go back to reference Hunter T, Pines J: Cyclins and cancer. II. Cyclin D and CDK inhibitors come of age. Cell. 1994, 79: 573-528. 10.1016/0092-8674(94)90543-6.CrossRefPubMed Hunter T, Pines J: Cyclins and cancer. II. Cyclin D and CDK inhibitors come of age. Cell. 1994, 79: 573-528. 10.1016/0092-8674(94)90543-6.CrossRefPubMed
6.
go back to reference Bartkova J, Lukas J, Strauss M, Bartek J: The PRAD-1/cyclin D1 oncogene product accumulates aberrantly in a subset of CRCs. Int J Cancer. 1994, 58: 568-573.CrossRefPubMed Bartkova J, Lukas J, Strauss M, Bartek J: The PRAD-1/cyclin D1 oncogene product accumulates aberrantly in a subset of CRCs. Int J Cancer. 1994, 58: 568-573.CrossRefPubMed
7.
go back to reference Motokura T, Arnold A: Cyclins and oncogenesis. Biochim Biophys Acta. 1993, 1155: 63-78. 10.1016/0304-419X(93)90022-5.PubMed Motokura T, Arnold A: Cyclins and oncogenesis. Biochim Biophys Acta. 1993, 1155: 63-78. 10.1016/0304-419X(93)90022-5.PubMed
8.
go back to reference Handa K, Yamakawa M, Takeda H, Kimura S, Takahashi T: Expression of the cell cycle markers in colorectal carcinoma: Superiority of cyclin A as an indicator of poor prognosis. Int J cancer. 1999, 84: 225-233. 10.1002/(SICI)1097-0215(19990621)84:3<225::AID-IJC5>3.3.CO;2-1.CrossRefPubMed Handa K, Yamakawa M, Takeda H, Kimura S, Takahashi T: Expression of the cell cycle markers in colorectal carcinoma: Superiority of cyclin A as an indicator of poor prognosis. Int J cancer. 1999, 84: 225-233. 10.1002/(SICI)1097-0215(19990621)84:3<225::AID-IJC5>3.3.CO;2-1.CrossRefPubMed
9.
go back to reference Gillett C, Fantl V, Smith R, Fisher C, Bartek J, Dickson C, Barnes D, Peters G: Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res. 1994, 54: 1812-1817.PubMed Gillett C, Fantl V, Smith R, Fisher C, Bartek J, Dickson C, Barnes D, Peters G: Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res. 1994, 54: 1812-1817.PubMed
10.
go back to reference Gown AM, Jiang JJ, Matles H, Skelly M, Goodpaster T, Cass L, Reshatof M, Spaulding D, Coltrera DM: Validation of the S-phase specificity of histone (H3) in situ hybridization in normal and malignant cells. J Histochem Cytochem. 1996, 44: 221-226.CrossRefPubMed Gown AM, Jiang JJ, Matles H, Skelly M, Goodpaster T, Cass L, Reshatof M, Spaulding D, Coltrera DM: Validation of the S-phase specificity of histone (H3) in situ hybridization in normal and malignant cells. J Histochem Cytochem. 1996, 44: 221-226.CrossRefPubMed
11.
go back to reference Nagao T, Ishida Y, Kondo Y: Determination of S-phase cells by in situ hybridization for histone H3 mRNA in hepatocellular carcinoma: correlation with histological grade and other cell proliferative markers. Mod Pathol. 1996, 9: 99-104.PubMed Nagao T, Ishida Y, Kondo Y: Determination of S-phase cells by in situ hybridization for histone H3 mRNA in hepatocellular carcinoma: correlation with histological grade and other cell proliferative markers. Mod Pathol. 1996, 9: 99-104.PubMed
12.
go back to reference Chou MY, Chang AL, McBride J, Donoff B, Gallagher GT, Wong DT: A rapid method to determine proliferation patterns of normal and malignant tissues by H3 mRNA in situ hybridization. Am J Pathol. 1990, 136: 729-733.PubMedPubMedCentral Chou MY, Chang AL, McBride J, Donoff B, Gallagher GT, Wong DT: A rapid method to determine proliferation patterns of normal and malignant tissues by H3 mRNA in situ hybridization. Am J Pathol. 1990, 136: 729-733.PubMedPubMedCentral
13.
go back to reference Sobin LH, Wittekind C: TNM classification of malignant tumors. 1997, John Wiley, New York, 5 Sobin LH, Wittekind C: TNM classification of malignant tumors. 1997, John Wiley, New York, 5
14.
go back to reference King RJ, Coffer AI, Gilbert J, Lewis K, Nash R, Millis R, Raju S, Taylor RW: Histochemical studies with a monoclonal antibody raised against a partially purified soluble estradiol receptor preparation from human myometrium. Cancer Res. 1985, 45: 5728-5733.PubMed King RJ, Coffer AI, Gilbert J, Lewis K, Nash R, Millis R, Raju S, Taylor RW: Histochemical studies with a monoclonal antibody raised against a partially purified soluble estradiol receptor preparation from human myometrium. Cancer Res. 1985, 45: 5728-5733.PubMed
15.
go back to reference Slebos RJ, Boerrigter L, Evers SG, Wisman P, Mooi WJ, Rodenhuis S: A rapid and simple procedure for the routine detection of ras point mutations in formalin-fixed, paraffin-embedded tissues. Diag Moln Path. 1992, 1: 136-141.CrossRef Slebos RJ, Boerrigter L, Evers SG, Wisman P, Mooi WJ, Rodenhuis S: A rapid and simple procedure for the routine detection of ras point mutations in formalin-fixed, paraffin-embedded tissues. Diag Moln Path. 1992, 1: 136-141.CrossRef
16.
go back to reference Jares P, Fernandez P, Campo E, Nadal A, Bosch F, Aiza G, Nayach I, Traserra J, Cardesa A: PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas. Cancer Res. 1994, 54: 4813-4817.PubMed Jares P, Fernandez P, Campo E, Nadal A, Bosch F, Aiza G, Nayach I, Traserra J, Cardesa A: PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas. Cancer Res. 1994, 54: 4813-4817.PubMed
17.
go back to reference Leach FS, Elledge SJ, Sherr CJ, Willson JK, Markowitz S, Kinzler KW, Vogelstein B: Amplification of cyclin genes in colorectal carcinomas. Cancer Res. 1993, 53: 1986-1989.PubMed Leach FS, Elledge SJ, Sherr CJ, Willson JK, Markowitz S, Kinzler KW, Vogelstein B: Amplification of cyclin genes in colorectal carcinomas. Cancer Res. 1993, 53: 1986-1989.PubMed
18.
go back to reference Arber N, Hibshoosh H, Moss SF, Sutter T, Zhang Y, Begg M, Wang S, Weinstein IB, Holt PR: Increased expression of cyclin D1 is an early event in multistage colorectal carcinogenesis. Gastroenterology. 1996, 110: 669-674.CrossRefPubMed Arber N, Hibshoosh H, Moss SF, Sutter T, Zhang Y, Begg M, Wang S, Weinstein IB, Holt PR: Increased expression of cyclin D1 is an early event in multistage colorectal carcinogenesis. Gastroenterology. 1996, 110: 669-674.CrossRefPubMed
19.
go back to reference Holland TA, Elder J, McCloud JM, Hall C, Deakin M, Fryer AA, Elder JB, Hoban PR: Subcellular localization of cyclin D1 protein in colorectal tumors is associated with p21 (WAF1/CIP1) expression and correlates with patient survival. Int J Cancer. 2001, 95 (5): 302-306. 10.1002/1097-0215(20010920)95:5<302::AID-IJC1052>3.0.CO;2-#.CrossRefPubMed Holland TA, Elder J, McCloud JM, Hall C, Deakin M, Fryer AA, Elder JB, Hoban PR: Subcellular localization of cyclin D1 protein in colorectal tumors is associated with p21 (WAF1/CIP1) expression and correlates with patient survival. Int J Cancer. 2001, 95 (5): 302-306. 10.1002/1097-0215(20010920)95:5<302::AID-IJC1052>3.0.CO;2-#.CrossRefPubMed
20.
go back to reference Pasz-Walczak G, Kordek R, faflik M: P21(WAF1) expression in colorectal cancer: correlation with p53 and cyclin D1 expression, clinicopathological parameters and prognosis. Pathol Res Pract. 2001, 197 (10): 683-689.CrossRefPubMed Pasz-Walczak G, Kordek R, faflik M: P21(WAF1) expression in colorectal cancer: correlation with p53 and cyclin D1 expression, clinicopathological parameters and prognosis. Pathol Res Pract. 2001, 197 (10): 683-689.CrossRefPubMed
21.
go back to reference Utsunomiya T, Doki Y, Takemoto H, Shiozaki H, Yano M, Sekimoto M, Tamura S, Yasuda T, Fujiwara Y, Monden M: Correlation of beta-catenin and cyclin D1 expression in colon cancers. Oncology. 2001, 61 (3): 226-233. 10.1159/000055379.CrossRefPubMed Utsunomiya T, Doki Y, Takemoto H, Shiozaki H, Yano M, Sekimoto M, Tamura S, Yasuda T, Fujiwara Y, Monden M: Correlation of beta-catenin and cyclin D1 expression in colon cancers. Oncology. 2001, 61 (3): 226-233. 10.1159/000055379.CrossRefPubMed
22.
go back to reference Maeda K, Chung YS, Kang SM, Ogawa M, Onoda N, Nakata B, Nishiguchi Y, Ikehara T, Okuno M, Sowa M: Overexpression of cyclin D1 and p53 is associated with disease recurrence in colorectal adenocarcinoma. Int JCancer. 1997, 74: 310-315. 10.1002/(SICI)1097-0215(19970620)74:3<310::AID-IJC13>3.0.CO;2-F.CrossRef Maeda K, Chung YS, Kang SM, Ogawa M, Onoda N, Nakata B, Nishiguchi Y, Ikehara T, Okuno M, Sowa M: Overexpression of cyclin D1 and p53 is associated with disease recurrence in colorectal adenocarcinoma. Int JCancer. 1997, 74: 310-315. 10.1002/(SICI)1097-0215(19970620)74:3<310::AID-IJC13>3.0.CO;2-F.CrossRef
23.
go back to reference McKay JA, Douglas JJ, Ross VG, Curran S, Loane JF, Ahmed FY, Cassidy J, McLeod HL, Murray GI: Analysis of key cell cycle checkpoint proteins in colorectal tumors. J Pathol. 2002, 196: 386-393. 10.1002/path.1053.CrossRefPubMed McKay JA, Douglas JJ, Ross VG, Curran S, Loane JF, Ahmed FY, Cassidy J, McLeod HL, Murray GI: Analysis of key cell cycle checkpoint proteins in colorectal tumors. J Pathol. 2002, 196: 386-393. 10.1002/path.1053.CrossRefPubMed
24.
go back to reference Mate JL, Ariza A, Aracil C, Lopez D, Isamat M, Perez-Piteira J, Navas-Palacios JJ: Cyclin D1 overexpression in non-small cell lung carcinoma: correlation with Ki-67 labeling index and poor cytoplasmic differentiation. J Pathol. 1996, 180: 395-399. 10.1002/(SICI)1096-9896(199612)180:4<395::AID-PATH688>3.0.CO;2-C.CrossRefPubMed Mate JL, Ariza A, Aracil C, Lopez D, Isamat M, Perez-Piteira J, Navas-Palacios JJ: Cyclin D1 overexpression in non-small cell lung carcinoma: correlation with Ki-67 labeling index and poor cytoplasmic differentiation. J Pathol. 1996, 180: 395-399. 10.1002/(SICI)1096-9896(199612)180:4<395::AID-PATH688>3.0.CO;2-C.CrossRefPubMed
25.
go back to reference Buckley MF, Sweeney KJ, Hamilton JA, Sini RL, Manning DL, Nicholson RI, DeFazio A, Watts CK, Musgrove EA, Sutherland RL: Expression and amplification of cyclin genes in human breast cancer. Oncogene. 1993, 8: 2127-2133.PubMed Buckley MF, Sweeney KJ, Hamilton JA, Sini RL, Manning DL, Nicholson RI, DeFazio A, Watts CK, Musgrove EA, Sutherland RL: Expression and amplification of cyclin genes in human breast cancer. Oncogene. 1993, 8: 2127-2133.PubMed
26.
go back to reference Habermann J, Lenander C, Roblick UJ, Kruger S, Ludwig D, Alaiya A, Freitag S, Dumbgen L, Bruch HP, Stange E, Salo S, Tryggvason K, Auer G, Schimmelpenning H: Ulcerative colitis and colorectal carcinoma: DNA profile, laminin-5 gamma 2 chain and cyclin A expression as early markers for risk assessment. Scand J Gastroenterol. 2001, 36: 751-758. 10.1080/003655201300192021.CrossRefPubMed Habermann J, Lenander C, Roblick UJ, Kruger S, Ludwig D, Alaiya A, Freitag S, Dumbgen L, Bruch HP, Stange E, Salo S, Tryggvason K, Auer G, Schimmelpenning H: Ulcerative colitis and colorectal carcinoma: DNA profile, laminin-5 gamma 2 chain and cyclin A expression as early markers for risk assessment. Scand J Gastroenterol. 2001, 36: 751-758. 10.1080/003655201300192021.CrossRefPubMed
27.
go back to reference Kubota Y, Petras RE, Easley KA, Bauer TW, Tubbe RR, Fazio VW: Ki-67-determined growth fraction versus standard staging and grading parameters in colorectal carcinoma. A multivariate analysis. Cancer. 1992, 70: 2602-2609.CrossRefPubMed Kubota Y, Petras RE, Easley KA, Bauer TW, Tubbe RR, Fazio VW: Ki-67-determined growth fraction versus standard staging and grading parameters in colorectal carcinoma. A multivariate analysis. Cancer. 1992, 70: 2602-2609.CrossRefPubMed
28.
go back to reference Shain AA, Ro JY, Brown RW, Ordonez NG, Cleary KR, El-Naggar AK, Wilson P, Ayala AG: Assessment of Ki-67-derived tumor proliferative activity in colorectal adenocarcinomas. Mod Pathol. 1994, 7: 17-22. Shain AA, Ro JY, Brown RW, Ordonez NG, Cleary KR, El-Naggar AK, Wilson P, Ayala AG: Assessment of Ki-67-derived tumor proliferative activity in colorectal adenocarcinomas. Mod Pathol. 1994, 7: 17-22.
29.
go back to reference Suzuki H, Matsumoto K, Terabe M: Ki-67 antibody labeling index in colorectal carcinoma. J clin Gastroenterol. 1992, 15: 317-320.CrossRefPubMed Suzuki H, Matsumoto K, Terabe M: Ki-67 antibody labeling index in colorectal carcinoma. J clin Gastroenterol. 1992, 15: 317-320.CrossRefPubMed
Metadata
Title
Cyclin A and cyclin D1 as significant prognostic markers in colorectal cancer patients
Authors
Abeer A Bahnassy
Abdel-Rahman N Zekri
Soumaya El-Houssini
Amal MR El-Shehaby
Moustafa Raafat Mahmoud
Samira Abdallah
Mostafa El-Serafi
Publication date
01-12-2004
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2004
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/1471-230X-4-22

Other articles of this Issue 1/2004

BMC Gastroenterology 1/2004 Go to the issue